Analysis of serotonin N-acetyltransferase regulation in vitro and in live cells using protein semisynthesis.
Serotonin N-acetyltransferase [arylalkylamine N-acetyltransferase (AANAT)] is a key circadian rhythm enzyme that drives the nocturnal production of melatonin in the pineal. Prior studies have suggested that its light and diurnal regulation involves phosphorylation on key AANAT Ser and Thr residues which results in 14-3-3zeta recruitment and changes in catalytic activity and protein stability. Here we use protein semisynthesis by expressed protein ligation to systematically explore the effects of single and dual phosphorylation of AANAT on acetyltransferase activity and relative affinity for 14-3-3zeta. AANAT Thr31 phosphorylation on its own can enhance catalytic efficiency up to 7-fold through an interaction with 14-3-3zeta that lowers the substrate K m. This augmented catalytic profile is largely abolished by double phosphorylation at Thr31 and Ser205. A possible basis for this difference is the dual anchoring of doubly phosphorylated AANAT via one 14-3-3zeta heterodimer. We have developed a novel solution phase assay for accurate K D measurements of 14-3-3zeta-AANAT interaction using 14-3-3zeta fluorescently labeled with rhodamine by expressed protein ligation. We have also generated a doubly fluorescently labeled AANAT which can be used to assess the stability of this protein in a live cell, real-time assay by fluorescence resonance energy transfer measured by microscopic imaging. These studies offer new insights into the molecular basis of melatonin regulation and 14-3-3zeta interaction.
Szewczuk
Lawrence M
LM
Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.
Tarrant
Mary K
MK
Sample
Vedangi
V
Drury
William J
WJ
Zhang
Jin
J
Cole
Philip A
PA
D000595:Amino Acid Sequence; D047068:Arylalkylamine N-Acetyltransferase / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*; D001665:Binding Sites; D002940:Circadian Rhythm; D003001:Cloning, Molecular; D017868:Cyclic AMP-Dependent Protein Kinases / Q000378:metabolism; D003545:Cysteine; D006706:Homeostasis; D006801:Humans; D008958:Models, Molecular; D008969:Molecular Sequence Data; D016254:Mutagenesis, Insertional; D010446:Peptide Fragments / Q000737:chemistry; D011487:Protein Conformation; D011994:Recombinant Proteins / Q000737:chemistry / Q000378:metabolism
D010446:Peptide Fragments; D011994:Recombinant Proteins; C478879:AANAT protein, human; D047068:Arylalkylamine N-Acetyltransferase; D017868:Cyclic AMP-Dependent Protein Kinases; D003545:Cysteine
J Am Chem Soc. 2003 Jun 18;125(24):7357-66
12797810
Trends Cell Biol. 1999 Feb;9(2):57-60
10087619
Annu Rev Pharmacol Toxicol. 2000;40:617-47
10836149
Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):6705-10
9618476
J Neuroendocrinol. 2003 Apr;15(4):370-7
12622836
Cell. 2001 Apr 20;105(2):257-67
11336675
Nat Rev Mol Cell Biol. 2002 Dec;3(12):906-18
12461557
Nat Struct Biol. 2003 Dec;10(12):1054-7
14578935
Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3199-203
7536927
J Biol Chem. 2007 Feb 16;282(7):4233-7
17164235
Annu Rev Pharmacol Toxicol. 1996;36:461-80
8725398
Anal Biochem. 2003 Jun 15;317(2):226-32
12758261
Chem Biol. 2000 Apr;7(4):253-61
10780925
J Biomol Screen. 2003 Feb;8(1):72-80
12855000
Recent Prog Horm Res. 1997;52:307-57; discussion 357-8
9238858
Science. 1998 Feb 27;279(5355):1358-60
9478897
Anal Biochem. 2006 Feb 15;349(2):186-96
16403428
J Biol Chem. 2005 Mar 18;280(11):10462-7
15632116
Chem Biol. 1996 Dec;3(12):981-91
9000009
Protein Sci. 1998 Nov;7(11):2256-64
9827992
Methods Enzymol. 2000;327:472-500
11045004
Trends Cell Biol. 1998 Oct;8(10):397-403
9789328
Proc Natl Acad Sci U S A. 2001 Jul 3;98(14):8083-8
11427721
J Biol Chem. 2002 Feb 1;277(5):3061-4
11709560
Annu Rev Biochem. 2000;69:923-60
10966479
J Biol Chem. 1998 Jan 30;273(5):3045-50
9446620
Proc Natl Acad Sci U S A. 2005 Jan 25;102(4):1222-7
15644438
Cell Mol Life Sci. 2002 Aug;59(8):1395-405
12363042